LEADER 01093nam0 22002893i 450 001 SUN0106148 005 20160721111723.720 010 $a88-420-4330-3$d0.00 100 $a20160720d1993 |0itac50 ba 101 $aita 102 $aIT 105 $a|||| ||||| 200 1 $aIl *pensiero politico di Constant$fStefano De Luca 210 $aRoma [etc.]$cLaterza$d1993 215 $a210 p.$d21 cm. 410 1$1001SUN0014668$12001 $aI *pensatori politici$v3$1210 $aRoma$aBari$cLaterza. 606 $aConstant, Benjamin$2EC$3SUNC032552 620 $dRoma$3SUNL000360 676 $a320.5$v21 700 0$aDe Luca, Stefano$3SUNV082405$0223380 712 $aLaterza$3SUNV000002$4650 801 $aIT$bSOL$c20181109$gRICA 912 $aSUN0106148 950 $aUFFICIO DI BIBLIOTECA DEL DIPARTIMENTO DI ECONOMIA$d03 PREST IVEb18 $e03 32591 995 $aUFFICIO DI BIBLIOTECA DEL DIPARTIMENTO DI ECONOMIA$bIT-CE0106$h32591$kPREST IVEb18$op$qa 996 $aPensiero politico di Constant$9564631 997 $aUNICAMPANIA LEADER 00831nam 2200265 450 001 9910845996103321 005 20240502144336.0 010 $a9781032654584 100 $a20240502d2023----u y0engy50 ba 101 0 $aeng 102 $aGB 105 0 $a 001yy 200 1 $aAdvances in Optical Networks and Components$fPartha Pratim Sahu 210 $aBoca Raton$cTaylor & Francis Ltd$d2023 215 $a466 p.$d23 cm 225 $aOptical networks and components$efundamentals and advances$v2 610 0 $aReti di calcolatori$aReti ottiche 700 1$aSahu,$bPartha Pratim$01654734 801 2$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a9910845996103321 952 $a10 C 716$bACQUIQUADRO03/2024$fDINEL 959 $aDINEL 996 $aAdvances in optical networks and components$94013361 997 $aUNINA LEADER 02050nam0 2200433 i 450 001 VAN0114830 005 20220307040548.649 017 70$2N$a978-4-431-55900-9 100 $a20180213d2016 |0itac50 ba 101 $aeng 102 $aJP 105 $a|||| ||||| 200 1 $aGroup-sequential clinical trials with multiple co-objectives$fToshimitsu Hamasaki ... [et al.] 210 $a[Tokyo]$cSpringer$d2016 215 $aIX, 113 p.$cill.$d24 cm 410 1$1001VAN0113968$12001 $aSpringerBriefs in Statistics. JSS research series in statistics$1210 $aBerlin [etc.]$cSpringer 500 1$3VAN0242415$aGroup-sequential clinical trials with multiple co-objectives$91523375 606 $a92-XX$xBiology and other natural sciences [MSC 2020]$3VANC020839$2MF 606 $a62P10$xApplications of statistics to biology and medical sciences; meta analysis [MSC 2020]$3VANC024649$2MF 606 $a92B15$xGeneral Biostatistics [MSC 2020]$3VANC026442$2MF 606 $a92C50$xMedical applications (general) [MSC 2020]$3VANC027825$2MF 606 $a62K05$xOptimal statistical designs [MSC 2020]$3VANC033803$2MF 610 $aGroup sequential designs$9KW:K 610 $aInterim Analysis$9KW:K 610 $aMultiple endpoints$9KW:K 610 $aNoninferiority$9KW:K 610 $aSample Size Recalculation$9KW:K 610 $aSample size calculation$9KW:K 620 $dTokyo$3VANL000048 702 1$aHamasaki$bToshimitsu$3VANV088857 712 $aSpringer $3VANV108073$4650 801 $aIT$bSOL$c20240614$gRICA 856 4 $uhttp://dx.doi.org/10.1007/978-4-431-55900-9$zE-book ? Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth 899 $aBIBLIOTECA CENTRO DI SERVIZIO SBA$2VAN15 912 $fN 912 $aVAN0114830 950 $aBIBLIOTECA CENTRO DI SERVIZIO SBA$d15CONS SBA EBOOK 2289 $e15EB 2289 20180213 996 $aGroup-sequential clinical trials with multiple co-objectives$91523375 997 $aUNICAMPANIA